A 40-year-old member asked: ...
Type 2 Diabetes Content on HealthTap (including answers) should not be used for medical advice, diagnosis, or treatment, and interactions on HealthTap do not create a doctor-patient relationship.
– Adenocard, a drug that Lyphomed Inc. wants to market for treating irregular heartbeats, was recommended for approval by a Food and Drug Administration advisory committee. Rosemont-based Lyphomed has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback